Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Fractionation and sorting of liver cell subpopulations.
  • Fig. S2. LV biodistribution within the liver cell subpopulations.
  • Fig. S3. Generation of CD47-negative cells.
  • Fig. S4. Generation of CD47-overexpressing cells.
  • Fig. S5. Cytokine and chemokine response to LV, CD47hi LV, or CD47-free LV administration in NOD mice.
  • Fig. S6. Cytokine and chemokine response to LV or CD47hi LV administration in NHPs.
  • Fig. S7. LV gene therapy in NHPs.
  • Fig. S8. IS analysis in CD47hi LV– or LV-treated NHP spleen.
  • Table S1. Large-scale LV batches used in NHP study.
  • Table S2. Clinical biochemistry, hematology, and hemostasis of vehicle NHP.
  • Table S3. Clinical biochemistry, hematology, and hemostasis of LV1.
  • Table S4. Clinical biochemistry, hematology, and hemostasis of LV2.
  • Table S5. Clinical biochemistry, hematology, and hemostasis of LV3.
  • Table S6. Clinical biochemistry, hematology, and hemostasis of CD47hi LV1.
  • Table S7. Clinical biochemistry, hematology, and hemostasis of CD47hi LV2.
  • Table S8. Clinical biochemistry, hematology, and hemostasis of CD47hi LV3.
  • Table S9. LV IS in NHPs.
  • Table S10. LV IS in cancer genes.
  • Table S11. LV CIS.
  • Legend for movie S1
  • References (4653)

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Movie S1 (.mov format). IV2PM of LVs, CD47hi LVs, or CD47-free LVs upon administration.